PGEN

PRECIGEN, INC.

Healthcare · Biotechnology

$245.61 sample

+0.62 (+0.25%) 1D

Market cap

$630.7B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-10

Alerts

8

Price$245.61 +7.61% 3M daily closessample

262.22228.25

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Chief Executive Officer
Sep 23INSInsider sell: Director
Sep 16INSInsider buy: EVP, Operations
Sep 10SEC10-Q filed
Sep 02INSInsider sell: Chief Executive Officer
Aug 26INSInsider sell: Chief Financial Officer
Aug 18INSInsider sell: EVP, Operations
Aug 13INSInsider buy: Director

Sign up to see the real PGEN record →

Company facts

SEC EDGAR registration

Name: PRECIGEN, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -50sample, -100 to +100
Reporting currency: USD

Who is positioning in PGEN

sample

Insiders: 25 insider transactions over 90 days, net selling, $536.6M
Congress: No member trades over 90 days
Institutions · 13F: 10 funds hold $6.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.0B +18.1% y/y

Q4 2024Q3 2026

Inventory$14.1B +14.6% y/y

Q4 2024Q3 2026

Accounts receivable$10.5B +9.5% y/y

Q4 2024Q3 2026

Total debt$28.0B +14.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $332.3B +16.1% 3M
Sample peer B: $287.7B +15.4% 3M
Sample peer C: $536.4B +6.8% 3M
Sample peer D: $89.0B -11.7% 3M
Sample peer E: $423.6B +5.6% 3M